The Solutions Explorer lets you create alerts that match your needs. You can create several alerts and you will receive a notification each time a new Solar Impulse Efficient Solutions is labeled and matches your filters.
Your Search Alerts will show up here.
Sign in to create alerts for your filters and search terms.
Sign inDon't have an account?
Sign upSyngulon Bacteriocins
Cost-effective antibiotic-free microbial selection to boost fermentation production
- About Company
Syngulon Bacteriocins
Cost-effective antibiotic-free microbial selection to boost fermentation production
Label Date
May 17, 2021
By
Syngulon
From
Belgium
Maturity stage
TRL 9 / CRI 2 - Commercial Trial Small Scale
The increasing regulatory requirements to which biological agents are subjected will have a great impact on all industries that use microbial fermentation-based production. There is an expectation that in the near future, zero-tolerance will apply to antibiotics. Besides the antibiotic itself, avoidance of using antibiotic resistance genes is clearly of critical importance because their complete absence is the only way to avoid their propagation in the environment or transfer of resistance to pathogenic bacteria. Syngulon antibiotic-free selection technology is based on the use of bacteriocins, discovered in 1925 by Belgian scientist Andre Gratia, that are natural antimicrobial peptide. Syngulon Solution is a cost-effective, antibiotic-free selection innovation to boost microbial fermentation.
The Environmental Benefits
- •100% reduction of antibiotic and antibiotic-resistance gene in the process and therefore in the environment - critical as Antimicrobial Resistance (AMR) is an increasingly serious threat to global public health
- •At least 20% energy reduction due to increased efficiency of fermentation-based production
The Financial Benefits
- •At least 25% yield increase for use in pharma, cosmetics or enzyme production industries when produced by microbial fermentation
- •Payback time of maximum 3 years
Target client profile
Tags
Applications
Benefits
Activity Region
- Headquarters
- Activity
Company Profile
Syngulon
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins.
Headquarters
4102 Seraing, Belgium
Type
Startup or self-employed
Related Topics
Complementary solutions
Share
Contact the Solution Provider
Add to Favorites
The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. This information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances. The innovator Syngulon has asserted ownership of the intellectual property rights for images, videos, and content showcased above, affirming full and unrestricted usage rights, and has provided explicit permission for the Solar Impulse Foundation to publish such information designated as "public" in the application form.